Zymergen Inc along with its affiliates, filed a motion for joint administration of their Chapter 11 bankruptcy cases in the US Bankruptcy Court on October 3, 2023. As per the motion, the debtor seeks the joint administration of the cases of its affiliates, Lodo Therapeutics Corporation, enEvolv, Inc., and Genesis Acquisition Sub, LLC, with its own case for administrative and procedural purposes. Zymergen Inc. has been proposed as the lead debtor.